ArticleItalian journal of food safety2025
Optimization of process conditions and kinetic microbial growth for milk fermentation using domestic kefir grains from Costa Rica.
Article in Italian journal of food safety, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Kefir, a fermented milk product, differs from yogurt due to its unique microbial composition, offering a broad spectrum of health benefits. Given its global popularity and high cost, there is a significant trend towards domestic kefir production. This study explores the optimization of kefir fermentation using Costa Rican domestic kefir grains, assessing the effects of temperature, agitation, and initial starter culture concentration. A central composite rotatable design and response surface statistical approach were employed to evaluate these parameters. Microbial growth data were fitted into a quadratic model, revealing significant interactions, particularly with temperature affecting both lactic acid bacteria (LAB) and yeast populations. Optimized fermentation conditions were established at 25°C, 0 rpm, and 5 g/L initial biomass, under which final microbial populations reached 9.45±0.13 log(cfu)/mL for yeast and 9.23±0.06 log(cfu)/mL for LAB. The specific growth velocity for kefir biomass was 0.029 1/h, and the total acid production rate was 0.060 g/(L h). Notably, the acetic acid production was significantly less than lactic acid, indicating a dominance of LAB over acetic acid bacteria, which is crucial for the desired flavor and health benefits of kefir. Additionally, microbial enumeration on glucose-yeast extract, calcium carbonate agar, and Rogosa agar showed distinct colony formations, highlighting the complex microbial interactions within kefir. This comprehensive dataset suggests that the performance of non-commercial starter cultures can be significantly improved under controlled conditions, providing a basis for developing guidelines for domestic kefir production. This study not only optimizes kefir production but also ensures that home-prepared kefir can meet quality standards, potentially enhancing its nutritional and therapeutic benefits.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.